Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utility of Management of Patients With CT and LDCT Identified Pulmonary Nodules Using the Percepta Nasal Swab Classifier

NCT06426628 is registered in ClinicalTrials.gov with Veracyte, Inc. as lead sponsor.

NCT NCT06426628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06426628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utility of Management of Patients With CT and LDCT Identified Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Lead sponsor
Veracyte, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 18, 2022
Completion date
March 31, 2027
Enrollment
2,400 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, pulmonary nodule, solitary